Why the J&J vaccine is SA’s best hope
Johnson & Johnson is expected to release its vaccine trial data later this week. If successful, it could be a promising development for SA
27 January 2021 - 08:30
A year into the coronavirus pandemic, elderly people most at risk of death from Covid-19, still stand in long, crowded queues in SA to access their social grants.
If the government is struggling to ensure monthly grant distribution is safe and automated, imagine the logistical difficulty of giving two doses of a vaccine, weeks apart, to millions of people in far-flung areas. To smooth the path of vaccinating 40-million people — the threshold government is aiming for — it would seem logical to try use a vaccine that is administered just once...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.